These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8948051)

  • 1. Binding of tissue factor pathway inhibitor to cultured endothelial cells-influence of glycosaminoglycans.
    Iversen N; Sandset PM; Abildgaard U; Torjesen PA
    Thromb Res; 1996 Nov; 84(4):267-78. PubMed ID: 8948051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of heparan sulfate proteoglycans in the uptake and degradation of tissue factor pathway inhibitor-coagulation factor Xa complexes.
    Ho G; Broze GJ; Schwartz AL
    J Biol Chem; 1997 Jul; 272(27):16838-44. PubMed ID: 9201990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor.
    Mast AE; Higuchi DA; Huang ZF; Warshawsky I; Schwartz AL; Broze GJ
    Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):577-83. PubMed ID: 9359432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.
    Wesselschmidt R; Likert K; Girard T; Wun TC; Broze GJ
    Blood; 1992 Apr; 79(8):2004-10. PubMed ID: 1562726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosaminoglycans increase levels of free and bioactive IGF-I in vitro.
    Møller AV; Jørgensen SP; Chen JW; Larnkjaer A; Ledet T; Flyvbjerg A; Frystyk J
    Eur J Endocrinol; 2006 Aug; 155(2):297-305. PubMed ID: 16868144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfation-dependent down-regulation of interferon-gamma-induced major histocompatibility complex class I and II and intercellular adhesion molecule-1 expression on tubular and endothelial cells by glycosaminoglycans.
    Yard BA; Lorentz CP; Herr D; van der Woude FJ
    Transplantation; 1998 Nov; 66(9):1244-50. PubMed ID: 9825824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: a segment, Gly212-Phe243, of the third Kunitz domain is a heparin-binding site.
    Enjyoji K; Miyata T; Kamikubo Y; Kato H
    Biochemistry; 1995 May; 34(17):5725-35. PubMed ID: 7727433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
    Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
    Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of heparin and other glycosaminoglycans on levels of tissue plasminogen activator and plasminogen activator inhibitor in cultured human umbilical vein endothelial cells.
    Marsh NA; Minter AJ; Chesterman CN
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):133-8. PubMed ID: 1966669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A kinetic analysis of the interaction of human recombinant tissue factor pathway inhibitor with factor Xa utilizing and immunoassay and the effect of antithrombin III/heparin on the complex formation.
    Kamikubo Y; Hamuro T; Takemoto S; Nakahara Y; Kamei S; Nakagaki T; Miyamoto S; Funatsu A; Kato H
    Thromb Res; 1998 Feb; 89(4):179-86. PubMed ID: 9651145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative quantification of glycosaminoglycan-induced upregulation of TFPI-mRNA expression in vitro.
    Thyzel E; Kohli S; Siegling S; Prante C; Kleesiek K; Götting C
    Thromb Res; 2007; 119(6):785-91. PubMed ID: 16919311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of urinary protein C inhibitor to cultured human epithelial kidney tumor cells (TCL-598). The role of glycosaminoglycans present on the luminal cell surface.
    Priglinger U; Geiger M; Bielek E; Vanyek E; Binder BR
    J Biol Chem; 1994 May; 269(20):14705-10. PubMed ID: 8182078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of depolymerized holothurian glycosaminoglycan (DHG) on tissue factor pathway inhibitor: in vitro and in vivo studies.
    Nagase H; Enjyoji K; Kamikubo Y; Kitazato KT; Kitazato K; Saito H; Kato H
    Thromb Haemost; 1997 Aug; 78(2):864-70. PubMed ID: 9268186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of new heparin-like compounds and other antithrombotic drugs and their interaction with vascular endothelial cells.
    Nader HB; Pinhal MA; Baú EC; Castro RA; Medeiros GF; Chavante SF; Leite EL; Trindade ES; Shinjo SK; Rocha HA; Tersariol IL; Mendes A; Dietrich CP
    Braz J Med Biol Res; 2001 Jun; 34(6):699-709. PubMed ID: 11378657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized low-density lipoprotein associates strongly with carboxy-terminal domain of tissue factor pathway inhibitor and reduces the catalytic activity of the protein.
    Horie S; Hiraishi S; Hamuro T; Kamikubo Y; Matsuda J
    Thromb Haemost; 2002 Jan; 87(1):80-5. PubMed ID: 11848461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of TFPI on thrombin and factor Xa generation in vitro--modulatory action of glycosaminoglycans.
    Kaiser B; Hoppensteadt DA; Jeske W; Wun TC; Fareed J
    Thromb Res; 1994 Sep; 75(6):609-16. PubMed ID: 7831680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological function of tissue factor pathway inhibitor and interaction with heparins.
    Sandset PM; Bendz B; Hansen JB
    Haemostasis; 2000; 30 Suppl 2():48-56. PubMed ID: 11251341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin and heparan sulfate bind interleukin-10 and modulate its activity.
    Salek-Ardakani S; Arrand JR; Shaw D; Mackett M
    Blood; 2000 Sep; 96(5):1879-88. PubMed ID: 10961890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II.
    Tovar AM; de Mattos DA; Stelling MP; Sarcinelli-Luz BS; Nazareth RA; Mourão PA
    Biochim Biophys Acta; 2005 Apr; 1740(1):45-53. PubMed ID: 15878740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.